SOX2 Protein

Migration, Crosslink

📖

SOX2 Protein

active

wiki page Created: 2026-04-02T07:19:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-sox2-protein

📖 Wiki Page

protein1634 wordssynced 2026-04-02

SOX2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SOX2 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">HMG Domain</td>
<td>39-121 aa</td>
</tr>
<tr>
<td class="label">Transactivation Domain</td>
<td>220-317 aa</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Ventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus (SGZ)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Gene Category</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Stemness</td>
<td>Nestin, Pax6</td>
</tr>
<tr>
<td class="label">Cell cycle</td>
<td>Cyclin D1, p21</td>
</tr>
<tr>
<td class="label">Neurogenesis</td>
<td>NeuroD1, Ascl1</td>
</tr>
<tr>
<td class="label">Extracellular matrix</td>
<td>laminin, fibronectin</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">OCT4</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">NANOG</td>
<td>Protein-protein</td>
</tr>
<tr>
<td class="label">KLF4</td>
<td>Cooperative</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>Co-a

...

SOX2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SOX2 Protein</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">HMG Domain</td>
<td>39-121 aa</td>
</tr>
<tr>
<td class="label">Transactivation Domain</td>
<td>220-317 aa</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Ventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Subventricular Zone</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus (SGZ)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Gene Category</td>
<td>Examples</td>
</tr>
<tr>
<td class="label">Stemness</td>
<td>Nestin, Pax6</td>
</tr>
<tr>
<td class="label">Cell cycle</td>
<td>Cyclin D1, p21</td>
</tr>
<tr>
<td class="label">Neurogenesis</td>
<td>NeuroD1, Ascl1</td>
</tr>
<tr>
<td class="label">Extracellular matrix</td>
<td>laminin, fibronectin</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">OCT4</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">NANOG</td>
<td>Protein-protein</td>
</tr>
<tr>
<td class="label">KLF4</td>
<td>Cooperative</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>Co-activator</td>
</tr>
<tr>
<td class="label">β-catenin</td>
<td>Signaling</td>
</tr>
<tr>
<td class="label">REST</td>
<td>Antagonistic</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">Alzheimer's Disease</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">371 edges</a></td>
</tr>
</table>

Overview

SOX2 (SRY-Box Transcription Factor 2) is a critical transcription factor that plays essential roles in maintaining pluripotency in embryonic stem cells, neural stem cell identity, neurogenesis, and neural development. As a member of the SOX (SRY-related HMG box) family of transcription factors, SOX2 recognizes and binds to specific DNA sequences through its high mobility group (HMG) domain, regulating gene expression programs essential for cell fate decisions and tissue development[@sox2_structure][@sox2_pluripotency].

In the central nervous system, SOX2 is indispensable for maintaining neural stem cell pools in both embryonic and adult brains, regulating the balance between stem cell maintenance and differentiation, and supporting hippocampal neurogenesis critical for learning and memory. Dysregulation of SOX2 has been implicated in various neurological disorders including Alzheimer's disease, Parkinson's disease, and neurodevelopmental disorders[@sox2_neural_stem][@sox2_brain].

Protein Structure and Function

Domain Architecture

SOX2 contains two primary functional domains:

The HMG domain recognizes the consensus sequence `(A/T)(A/T)CAA(A/T)G` and bends DNA upon binding, facilitating interaction with co-factors and other transcription factors. The C-terminal transactivation domain recruits transcriptional co-activators including p300/CBP and mediates transcriptional activation of target genes[@sox2_structure].

DNA Binding Mechanism

SOX2 binds DNA as a monomer, with the HMG domain inserted into the minor groove of DNA, causing a significant bend (approximately 60-80 degrees) in the DNA helix. This bending facilitates the assembly of transcriptional complexes at target gene promoters and enhancers.

Expression and Localization

Brain Expression

SOX2 exhibits specific expression patterns in the nervous system[@sox2_brain][@sox2_neural_stem]:

Cellular Localization

Nuclear localization: SOX2 functions as a transcription factor in the nucleus
Dynamic localization: Can shuttle between cytoplasm and nucleus
Cell-type specificity: Expression varies by developmental stage and brain region

Normal Physiological Functions

Pluripotency Maintenance

SOX2 is one of the core transcription factors (along with OCT4, NANOG, and SOX2) that maintain pluripotency in embryonic stem cells[@sox2_pluripotency][@sox2_ipsc]:

Self-renewal: SOX2 prevents differentiation by activating pluripotency genes
Reprogramming: SOX2 is essential for generating induced pluripotent stem cells (iPSCs)
Lineage specification: Helps direct cells toward neural lineages

Neural Stem Cell Maintenance

In the adult brain, SOX2 maintains neural stem cell populations[@sox2_neural_stem]:

Ventral subventricular zone (SVZ): Maintains neural stem cell pool
Dentate gyrus subgranular zone (SGZ): Supports hippocampal neurogenesis
Quiescence: Helps maintain stem cells in quiescent state
Activation: Promotes entry into cell cycle when needed

Neurogenesis Regulation

SOX2 plays crucial roles in neurogenesis throughout development and in adulthood[@sox2_neurogenesis][@sox2_differentiation]:

Proliferation: Regulates neural progenitor proliferation
Differentiation: Promotes neuronal differentiation over glial
Migration: Coordinates neuronal migration
Maturation: Helps neurons acquire proper identity

Astrocyte Development

Beyond neurons, SOX2 also influences glial development[@sox2_glia]:

Astrocyte specification: Directs progenitors toward astrocyte fate
Glial maturation: Supports astrocyte differentiation
Function: Maintains astrocyte identity in mature brain

Role in Neurodegenerative Diseases

Alzheimer's Disease

SOX2 dysfunction has been implicated in Alzheimer's disease pathogenesis[@sox2_ad]:

Neurogenesis Impairment

Hippocampal neurogenesis decline: SOX2-expressing neural stem cells in the dentate gyrus show reduced activity in AD
Cognitive decline correlation: Reduced neurogenesis correlates with memory deficits
Amyloid effects: Aβ may suppress SOX2 expression and function

Stem Cell Dysfunction

Neural stem cell exhaustion: Progressive decline in SOX2+ cell function
Inflammation effects: Inflammatory milieu impairs SOX2 activity
Therapeutic potential: Enhancing SOX2 may support regeneration

Parkinson's Disease

SOX2 plays roles in dopaminergic neuron biology relevant to PD[@sox2_parkinson]:

Development and Maintenance

Dopaminergic neuron development: SOX2 essential for proper development
Maintenance in adulthood: Supports adult dopaminergic neurons
Vulnerability: May contribute to selective vulnerability of dopaminergic neurons

Regenerative Potential

Cell replacement therapy: SOX2-derived neurons as transplant candidates
Reprogramming: Direct conversion using SOX2
Regeneration promotion: Enhancing SOX2 to support repair

Neurodevelopmental Disorders

SOX2 mutations cause severe neurodevelopmental disorders[@sox2_mutation][@sox2_ndd]:

Clinical Features

Anophthalmia/microphthalmia: Eye development defects
Severe intellectual disability: Profound cognitive impairment
Seizures: Epilepsy in affected individuals
Brain malformations: Structural brain abnormalities

Molecular Mechanisms

Haploinsufficiency: One functional copy insufficient
Dominant-negative effects: Mutant proteins may interfere
Transcriptional dysregulation: Altered gene expression programs

Autism Spectrum Disorder

SOX2 is implicated in ASD through genetic and expression studies[@sox2_asd]:

Genetic variants: SOX2 mutations associated with ASD risk
Expression changes: Altered SOX2 expression in ASD brains
Synaptic function: SOX2 regulates synaptic genes

Schizophrenia

Alterations in SOX2 have been reported in schizophrenia[@sox2_schizophrenia]:

Expression changes: Reduced SOX2 in prefrontal cortex
Developmental hypothesis: Early developmental disruption
Glutamate signaling: Interaction with glutamate system

Aging

SOX2 expression declines with age in the brain[@sox2_aging]:

Stem cell decline: Reduced neural stem cell function
Neurogenesis decrease: Age-related neurogenesis reduction
Cognitive decline: Correlates with age-related cognitive deficits

Gene Regulatory Network

Core Transcription Factors

SOX2 participates in the pluripotency network:

OCT4 (POU5F1): Cooperative binding and mutual activation
NANOG: Direct protein-protein interaction
KLF4: Synergistic transcriptional activation

Target Genes

SOX2 regulates numerous genes important for neural stem cells[@sox2_target_genes]:

Epigenetic Regulation

SOX2 expression and activity are epigenetically regulated[@sox2_epigenetics]:

DNA methylation: Promoter methylation silences SOX2
Histone modifications: Active histone marks at SOX2 locus
Chromatin remodeling: Accessible chromatin in stem cells

Therapeutic Implications

Cell-Based Therapies

SOX2 is central to regenerative approaches[@sox2_reprogramming][@sox2_therapy]:

iPSC Technology

Reprogramming factor: SOX2 is one of Yamanaka factors
Disease modeling: Patient-derived iPSCs for drug screening
Cell therapy: Differentiated neurons for transplantation

Direct Reprogramming

Fibroblast conversion: SOX2 enables direct conversion
Glia-to-neuron: Converting astrocytes to neurons
In vivo reprogramming: Potential for brain repair

Gene Therapy

Approaches to enhance SOX2:

Viral vectors: AAV-mediated SOX2 expression
Small molecules: Activate endogenous SOX2
CRPR/Cas9: Target SOX2 locus precisely

Pharmacological Approaches

Epigenetic drugs: HDAC inhibitors to increase SOX2
Growth factors: BDNF promotes SOX2 activity
Exercise: Physical activity enhances neurogenesis via SOX2

Interaction Network

Protein Interactions

Signaling Pathways

SOX2 integrates with multiple signaling pathways:

Wnt/β-catenin: Cross-talk with stemness pathways
BMP signaling: Antagonizes glial differentiation
Notch signaling: Maintains stem cell state
FGF signaling: Supports proliferation

Research Methods

Detection and Analysis

Immunohistochemistry: Protein localization in brain tissue
RNA-seq: Transcriptomic profiling of SOX2+ cells
ChIP-seq: Genome-wide binding analysis
ATAC-seq: Chromatin accessibility

Functional Studies

Knockout mice: SOX2 conditional deletion
iPSC models: Patient-derived cells
Organoids: Brain organoid models

Manipulation

CRISPR/Cas9: Precise genetic editing
Optogenetics: Light-controlled SOX2 activity
Chemical genetics: Inducible SOX2 activation

Conclusion

SOX2 is a master regulatory transcription factor essential for neural stem cell maintenance, neurogenesis, and brain development. Its dysregulation contributes to neurodegenerative and neurodevelopmental disorders, while its central role in pluripotency and cellular reprogramming makes it a key target for regenerative medicine approaches. Understanding SOX2 function and developing therapies to modulate its activity hold promise for treating neurological conditions affecting learning, memory, and motor function.

External Links

[UniProt: SOX2 (P35745)](https://www.uniprot.org/uniprot/P35745)
[NCBI Gene: SOX2](https://www.ncbi.nlm.nih.gov/gene/6657)
[PDB: SOX2 HMG domain](https://www.rcsb.org/structure/1O4X)
[Human Protein Atlas: SOX2](https://www.proteinatlas.org/ENSG00000181449-SOX2)

References

[Dang J, et al., Structure of the SOX2 HMG domain (2000)](https://pubmed.ncbi.nlm.nih.gov/10700179/)

[Avilion AA, et al., SOX2 is required for maintenance of pluripotency in embryonic stem cells (2003)](https://pubmed.ncbi.nlm.nih.gov/12502787/)

[Suh H, et al., SOX2 maintains neural stem cell identity in the adult brain (2007)](https://pubmed.ncbi.nlm.nih.gov/17641388/)

[Graham V, et al., SOX2 regulates neural progenitor identity and neurogenesis (2003)](https://pubmed.ncbi.nlm.nih.gov/14729483/)

[Ferri AL, et al., SOX2 expression in the developing and adult mouse brain (2004)](https://pubmed.ncbi.nlm.nih.gov/14766904/)

[Tahmasebi S, et al., SOX2 and autism spectrum disorder (2019)](https://pubmed.ncbi.nlm.nih.gov/30647434/)

[Kareem MA, et al., SOX2 expression in Alzheimer's disease brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32007922/)

[Matsumaru D, et al., SOX2 in neurodevelopmental disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/33439518/)

[Bhardwaj D, et al., SOX2 promotes neuronal differentiation (2007)](https://pubmed.ncbi.nlm.nih.gov/17553906/)

[Kang P, et al., SOX2 controls astrocyte development (2012)](https://pubmed.ncbi.nlm.nih.gov/22002804/)

[Takahashi K, et al., Induction of pluripotent stem cells from human fibroblasts (2007)](https://pubmed.ncbi.nlm.nih.gov/18035408/)

[Lujan E, et al., SOX2 in cellular reprogramming (2012)](https://pubmed.ncbi.nlm.nih.gov/22069266/)

[Blau HM, et al., SOX2 and neural regeneration (2013)](https://pubmed.ncbi.nlm.nih.gov/24315443/)

[Toyoda T, et al., SOX2 expression in schizophrenia brain (2014)](https://pubmed.ncbi.nlm.nih.gov/24717642/)

[Kumar A, et al., SOX2 decline in aging brain (2018)](https://pubmed.ncbi.nlm.nih.gov/29388831/)

[Willis CM, et al., SOX2-based therapies for neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32822583/)

[Lengner CJ, et al., SOX2 epigenetics and transcriptional regulation (2010)](https://pubmed.ncbi.nlm.nih.gov/20188811/)

[Chen X, et al., SOX2 target gene network in neural stem cells (2010)](https://pubmed.ncbi.nlm.nih.gov/20452317/)

[Marques MM, et al., SOX2 and cell cycle regulation in neural stem cells (2013)](https://pubmed.ncbi.nlm.nih.gov/24369834/)

[Wang S, et al., SOX2 in dopaminergic neuron development (2021)](https://pubmed.ncbi.nlm.nih.gov/33893221/)

[Liu J, et al., iPSC models of SOX2-related disorders (2019)](https://pubmed.ncbi.nlm.nih.gov/30612957/)

[Kamps RA, et al., SOX2 mutations cause anophthalmia and neurodevelopmental defects (2006)](https://pubmed.ncbi.nlm.nih.gov/16501573/)

📖 View canonical wiki page →

Related Entities

SOX2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-sox2-protein
kg_node_id	SOX2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9a63575c2c2d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-sox2-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

14

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

SOX2 Protein

SOX2 Protein

SOX2 Protein

Overview

Protein Structure and Function

Domain Architecture

DNA Binding Mechanism

Expression and Localization

Brain Expression

Cellular Localization

Normal Physiological Functions

Pluripotency Maintenance

Neural Stem Cell Maintenance

Neurogenesis Regulation

Astrocyte Development

Role in Neurodegenerative Diseases

Alzheimer's Disease

Neurogenesis Impairment

Stem Cell Dysfunction

Parkinson's Disease

Development and Maintenance

Regenerative Potential

Neurodevelopmental Disorders

Clinical Features

Molecular Mechanisms

Autism Spectrum Disorder

Schizophrenia

Aging

Gene Regulatory Network

Core Transcription Factors

Target Genes

Epigenetic Regulation

Therapeutic Implications

Cell-Based Therapies

iPSC Technology

Direct Reprogramming

Gene Therapy

Pharmacological Approaches

Interaction Network

Protein Interactions

Signaling Pathways

Research Methods

Detection and Analysis

Functional Studies

Manipulation

Conclusion

See Also

External Links

References

💬 Discussion